Crossref
Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML
Evidence-based Oncology · 2000
DOI: 10.1054/ebon.2000.0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-based Oncology, 2000. Verfasst von Martin S. Tallman. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tallman, M. S. (2000). Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML. Evidence-based Oncology. https://doi.org/10.1054/ebon.2000.0012
Vancouver
Tallman MS. Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML. Evidence-based Oncology. 2000. doi:10.1054/ebon.2000.0012
BibTeX
@article{Tallman2000,
author = {Tallman, Martin S.},
title = {Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML},
journal = {Evidence-based Oncology},
year = {2000},
doi = {10.1054/ebon.2000.0012}
}
EUVIMED